Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

Telemedicine for certain conditions may be cheaper and lead to fewer short-term follow-up visits, reducing the overall cost of care burden.

The HHS pushes for additional nutrition training in medical schools, some experts agree but approach the implementation with skepticism.

Adolescent cannabis use is associated with an increased risk for new psychiatric disorders during key developmental stages.

FDA expands Juxtapid approval for pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia to reduce plasma LDL-C levels.